3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
2
Phase 3
1
Status
Unknown
2
Withdrawn
1
Recruiting
1
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER_GOV
1
OTHER
1
Study Type
Interventional
2
Sponsor
Cancer Type
Classical hematology
2
Conditions
Febrile Neutropenia
2
Sepsis
1
Neoplasms
1
Fever
1
Emergencies
1
Interventions
Metformin
16
Cyclophosphamide
15
Drug Therapy
14
Dexamethasone
14
Cisplatin
14
Cytarabine
11
Gemcitabine
10
Radiotherapy
9
Carboplatin
9
Vincristine
8
Paclitaxel
8
Oxaliplatin
8
Idarubicin
8
Etoposide
8
Docetaxel
8
ulipristal acetate
7
icotinib
7
Sodium Chloride
7
Methotrexate
7
Fluorouracil
7
Dexmedetomidine
7
entecavir
6
Thalidomide
6
Surgical Procedures, Operative
6
Sorafenib
6
Pemetrexed
6
Leuprolide
6
Granulocyte Colony-Stimulating Factor
6
Epirubicin
6
Doxorubicin
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 4
×
Unknown
×
Meropenem
×
Clear all
NCT05393505
2022-12-06
FRANCiS-NF
The University of Hong Kong
Phase 4
Unknown
344 enrolled
NCT02463747
2015-06-04
RR
Tel-Aviv Sourasky Medical Center
Phase 4
Unknown
110 enrolled